Product Composition

Each film-coated tablet contains:

• Acebrophylline (SR): 200 mg.

• Montelukast Sodium: Equivalent to Montelukast 10 mg.

• Desloratadine: 5 mg.

• Excipients: q.s..

• Color: Approved colour used.

Product Summary

Deslaw-3D is a triple-combination respiratory medication marketed by Healthgate. It combines a mucolytic/bronchodilator (Acebrophylline in sustained-release form), a leukotriene receptor antagonist (Montelukast), and a long-acting antihistamine (Desloratadine). This formula is designed to provide comprehensive management for complex respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD) accompanied by allergic rhinitis.

Pros and Cons

Pros

• Three-in-One Action: Targets airway constriction, mucus buildup, and allergic inflammation simultaneously.

• Extended Relief: The sustained-release (SR) Acebrophylline component provides a gradual release of medication for prolonged effect.

• Non-Drowsy Antihistamine: Includes Desloratadine, which is generally known for its low potential to cause drowsiness.

Cons

• Complexity: Taking multiple active ingredients in one tablet can make it harder to identify the specific cause if an adverse reaction occurs.

• Potential Side Effects: May cause common issues such as headache, dry mouth, or gastrointestinal discomfort.

• Strict Administration: Requires careful adherence to swallowing the tablet whole to maintain the sustained-release mechanism.

How to Use

• Administration: The tablet should be swallowed whole and not be chewed or crushed. Breaking the tablet can interfere with the sustained-release (SR) properties.

• Dosage: Use exactly as directed by the Physician.

• Storage: Store in a cool, dry, and dark place at a temperature below 25°C. Protect the medication from light and moisture.

• Safety: Keep all medicines out of the reach of children.

Warning: This is a Schedule H Prescription Drug and should be sold by retail on the prescription of a Registered Medical Practitioner only.